BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,132 filers reported holding BAXTER INTL INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $112,586 | -9.9% | 3,185 | +8.9% | 0.00% | 0.0% |
Q1 2024 | $125,004 | +8.0% | 2,925 | -2.3% | 0.00% | 0.0% |
Q4 2023 | $115,714 | +148.4% | 2,993 | +142.5% | 0.00% | – |
Q3 2023 | $46,576 | +23.4% | 1,234 | +48.9% | 0.00% | – |
Q2 2023 | $37,750 | -4.6% | 829 | -15.1% | 0.00% | – |
Q1 2023 | $39,585 | +18.6% | 976 | +49.0% | 0.00% | – |
Q4 2022 | $33,379 | -12.2% | 655 | -7.1% | 0.00% | – |
Q3 2022 | $38,000 | -34.5% | 705 | -22.0% | 0.00% | -100.0% |
Q2 2022 | $58,000 | +56.8% | 904 | +90.7% | 0.00% | – |
Q1 2022 | $37,000 | -31.5% | 474 | -24.9% | 0.00% | -100.0% |
Q4 2021 | $54,000 | -11.5% | 631 | -17.2% | 0.00% | 0.0% |
Q3 2021 | $61,000 | +10.9% | 762 | +11.2% | 0.00% | 0.0% |
Q2 2021 | $55,000 | +223.5% | 685 | +242.5% | 0.00% | – |
Q1 2021 | $17,000 | +54.5% | 200 | +39.9% | 0.00% | – |
Q4 2020 | $11,000 | -8.3% | 143 | 0.0% | 0.00% | – |
Q3 2020 | $12,000 | -55.6% | 143 | -54.3% | 0.00% | -100.0% |
Q2 2020 | $27,000 | +125.0% | 313 | +118.9% | 0.00% | – |
Q1 2020 | $12,000 | 0.0% | 143 | 0.0% | 0.00% | – |
Q4 2019 | $12,000 | -7.7% | 143 | 0.0% | 0.00% | – |
Q3 2019 | $13,000 | +8.3% | 143 | 0.0% | 0.00% | – |
Q2 2019 | $12,000 | 0.0% | 143 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $12,000 | +33.3% | 143 | 0.0% | 0.00% | – |
Q4 2018 | $9,000 | -18.2% | 143 | 0.0% | 0.00% | – |
Q3 2018 | $11,000 | +37.5% | 143 | +30.0% | 0.00% | – |
Q2 2018 | $8,000 | +14.3% | 110 | +6.8% | 0.00% | -100.0% |
Q1 2018 | $7,000 | 0.0% | 103 | -1.0% | 0.00% | 0.0% |
Q4 2017 | $7,000 | +16.7% | 104 | +3.0% | 0.00% | – |
Q3 2017 | $6,000 | 0.0% | 101 | 0.0% | 0.00% | -100.0% |
Q2 2017 | $6,000 | +20.0% | 101 | 0.0% | 0.00% | – |
Q1 2017 | $5,000 | +25.0% | 101 | 0.0% | 0.00% | – |
Q4 2016 | $4,000 | -20.0% | 101 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $5,000 | 0.0% | 101 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $5,000 | +25.0% | 101 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $4,000 | 0.0% | 101 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $4,000 | +33.3% | 101 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $3,000 | -57.1% | 101 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $7,000 | 0.0% | 101 | 0.0% | 0.00% | -33.3% |
Q1 2015 | $7,000 | – | 101 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |